Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

The airway microbiota in children newly diagnosed with bronchiectasis largely retains its diversity.

Pillarisetti N, Broderick D, Ainsworth A, Mulholland A, Wagner Mackenzie B, Middleton D, Byrnes CA, Taylor MW.

Eur Respir J. 2019 Apr 25. pii: 1900704. doi: 10.1183/13993003.00704-2019. [Epub ahead of print] No abstract available.

PMID:
31023855
2.

HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial.

Chang AB, Fong SM, Yeo TW, Ware RS, McCallum GB, Nathan AM, Ooi MH, de Bruyne J, Byrnes CA, Lee B, Nachiappan N, Saari N, Torzillo P, Smith-Vaughan H, Morris PS, Upham JW, Grimwood K.

BMJ Open. 2019 Apr 24;9(4):e026411. doi: 10.1136/bmjopen-2018-026411.

3.

Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.

Goyal V, Grimwood K, Byrnes CA, Morris PS, Masters IB, Ware RS, McCallum GB, Binks MJ, Marchant JM, van Asperen P, O'Grady KF, Champion A, Buntain HM, Petsky H, Torzillo PJ, Chang AB.

Lancet. 2018 Oct 6;392(10154):1197-1206. doi: 10.1016/S0140-6736(18)31723-9. Epub 2018 Sep 18.

PMID:
30241722
4.

Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention.

Bell SC, Elborn JS, Byrnes CA.

Respirology. 2018 Nov;23(11):1006-1022. doi: 10.1111/resp.13398. Epub 2018 Sep 11. Review.

5.

Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Hare KM, Grimwood K, Chang AB, Chatfield MD, Valery PC, Leach AJ, Smith-Vaughan HC, Morris PS, Byrnes CA, Torzillo PJ, Cheng AC.

Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2275-85. doi: 10.1007/s10096-015-2480-0. Epub 2015 Sep 12.

PMID:
26363637
6.

Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.

McCallum GB, Morris PS, Grimwood K, Maclennan C, White AV, Chatfield MD, Sloots TP, Mackay IM, Smith-Vaughan H, McKay CC, Versteegh LA, Jacobsen N, Mobberley C, Byrnes CA, Chang AB.

Front Pediatr. 2015 Apr 21;3:32. doi: 10.3389/fped.2015.00032. eCollection 2015.

7.

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines.

Chang AB, Bell SC, Torzillo PJ, King PT, Maguire GP, Byrnes CA, Holland AE, O'Mara P, Grimwood K; extended voting group.

Med J Aust. 2015 Feb 16;202(3):130. No abstract available.

PMID:
25669469
8.

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines.

Chang AB, Bell SC, Torzillo PJ, King PT, Maguire GP, Byrnes CA, Holland AE, O'Mara P, Grimwood K; extended voting group.

Med J Aust. 2015 Jan 19;202(1):21-3. No abstract available. Erratum in: Med J Aust. 2015 Feb 16;202(3):130.

PMID:
25588439
9.

Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis.

Moodie M, Lal A, Vidmar S, Armstrong DS, Byrnes CA, Carlin JB, Cheney J, Cooper PJ, Grimwood K, Robertson CF, Tiddens HA, Wainwright CE; Australasian Cystic Fibrosis Bronchoalveolar Lavage Study Investigators.

J Pediatr. 2014 Sep;165(3):564-569.e5. doi: 10.1016/j.jpeds.2014.05.031. Epub 2014 Jul 1.

PMID:
24996984
10.

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.

Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB.

Lancet Respir Med. 2013 Oct;1(8):610-620. doi: 10.1016/S2213-2600(13)70185-1. Epub 2013 Sep 17. Erratum in: Lancet Respir Med. 2015 Aug;3(8):e29.

PMID:
24461664
11.

Heated humidification improves clinical outcomes, compared to a heat and moisture exchanger in children with tracheostomies.

McNamara DG, Asher MI, Rubin BK, Stewart A, Byrnes CA.

Respir Care. 2014 Jan;59(1):46-53. doi: 10.4187/respcare.02214. Epub 2013 Jun 13.

12.

Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.

Chang AB, Grimwood K, Wilson AC, van Asperen PP, Byrnes CA, O'Grady KA, Sloots TP, Robertson CF, Torzillo PJ, McCallum GB, Masters IB, Buntain HM, Mackay IM, Ungerer J, Tuppin J, Morris PS.

Trials. 2013 Feb 20;14:53. doi: 10.1186/1745-6215-14-53.

13.

Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Singleton RJ, Valery PC, Morris P, Byrnes CA, Grimwood K, Redding G, Torzillo PJ, McCallum G, Chikoyak L, Mobberly C, Holman RC, Chang AB.

Pediatr Pulmonol. 2014 Feb;49(2):189-200. doi: 10.1002/ppul.22763. Epub 2013 Feb 8.

PMID:
23401398
14.

Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.

Byrnes CA, Vidmar S, Cheney JL, Carlin JB, Armstrong DS, Cooper PJ, Grimwood K, Moodie M, Robertson CF, Rosenfeld M, Tiddens HA, Wainwright CE; ACFBAL Study Investigators.

Thorax. 2013 Jul;68(7):643-51. doi: 10.1136/thoraxjnl-2012-202342. Epub 2013 Jan 23.

15.

Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection.

Trenholme AA, Byrnes CA, McBride C, Lennon DR, Chan-Mow F, Vogel AM, Stewart JM, Percival T.

Pediatr Pulmonol. 2013 Aug;48(8):772-9. doi: 10.1002/ppul.22661. Epub 2012 Sep 19.

PMID:
22997178
16.

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.

Chang AB, Grimwood K, Robertson CF, Wilson AC, van Asperen PP, O'Grady KA, Sloots TP, Torzillo PJ, Bailey EJ, McCallum GB, Masters IB, Byrnes CA, Chatfield MD, Buntain HM, Mackay IM, Morris PS.

Trials. 2012 Aug 31;13:156. doi: 10.1186/1745-6215-13-156.

17.

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.

Valery PC, Morris PS, Grimwood K, Torzillo PJ, Byrnes CA, Masters IB, Bauert PA, McCallum GB, Mobberly C, Chang AB.

BMC Pediatr. 2012 Aug 14;12:122.

18.

Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.

Wainwright CE, Vidmar S, Armstrong DS, Byrnes CA, Carlin JB, Cheney J, Cooper PJ, Grimwood K, Moodie M, Robertson CF, Tiddens HA; ACFBAL Study Investigators.

JAMA. 2011 Jul 13;306(2):163-71. doi: 10.1001/jama.2011.954.

PMID:
21750293
19.

Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis.

Chang AB, Byrnes CA, Everard ML.

Paediatr Respir Rev. 2011 Jun;12(2):97-103. doi: 10.1016/j.prrv.2010.10.008. Epub 2010 Dec 4.

PMID:
21458737
20.

Respiratory infections in Tamariki (children) and Taitamariki (young people) Māori, New Zealand.

Byrnes CA, Trenholme A.

J Paediatr Child Health. 2010 Sep;46(9):521-6. doi: 10.1111/j.1440-1754.2010.01853.x. Review.

PMID:
20854324
21.

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand.

Chang AB, Bell SC, Byrnes CA, Grimwood K, Holmes PW, King PT, Kolbe J, Landau LI, Maguire GP, McDonald MI, Reid DW, Thien FC, Torzillo PJ.

Med J Aust. 2010 Sep 20;193(6):356-65.

PMID:
20854242
22.

Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?

Munro KA, Reed PW, Joyce H, Perry D, Twiss J, Byrnes CA, Edwards EA.

Pediatr Pulmonol. 2011 Feb;46(2):131-8. doi: 10.1002/ppul.21331. Epub 2010 Aug 17.

PMID:
20717910
23.

A prospective randomized trial comparing supraglottic airways for flexible bronchoscopy in children.

Baker PA, Brunette KE, Byrnes CA, Thompson JM.

Paediatr Anaesth. 2010 Sep;20(9):831-8. doi: 10.1111/j.1460-9592.2010.03362.x.

PMID:
20716075
24.

Chronic respiratory symptoms and diseases among indigenous children.

Redding GJ, Byrnes CA.

Pediatr Clin North Am. 2009 Dec;56(6):1323-42. doi: 10.1016/j.pcl.2009.09.012. Review.

PMID:
19962024
25.

The perceptions and preferences of parents of children with tracheostomies in a study of humidification therapy.

McNamara DG, Dickinson AR, Byrnes CA.

J Child Health Care. 2009 Sep;13(3):179-97. doi: 10.1177/1367493509336686.

PMID:
19713403
26.

Safety of bronchoalveolar lavage in young children with cystic fibrosis.

Wainwright CE, Grimwood K, Carlin JB, Vidmar S, Cooper PJ, Francis PW, Byrnes CA, Whitehead BF, Martin AJ, Robertson IF, Cooper DM, Dakin CJ, Masters IB, Massie RJ, Robinson PJ, Ranganathan S, Armstrong DS, Patterson LK, Robertson CF.

Pediatr Pulmonol. 2008 Oct;43(10):965-72. doi: 10.1002/ppul.20885.

PMID:
18780333
27.

Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients.

McMorran BJ, Patat SA, Carlin JB, Grimwood K, Jones A, Armstrong DS, Galati JC, Cooper PJ, Byrnes CA, Francis PW, Robertson CF, Hume DA, Borchers CH, Wainwright CE, Wainwright BJ.

Clin Chem. 2007 Oct;53(10):1782-91. Epub 2007 Aug 16.

28.

Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis.

Twiss J, Stewart AW, Byrnes CA.

Thorax. 2006 May;61(5):414-8. Epub 2006 Feb 7.

29.

Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.

Thomson JM, Wesley A, Byrnes CA, Nixon GM.

Pediatr Pulmonol. 2006 Feb;41(2):164-70.

PMID:
16317722
30.

Cinacalcet: a new treatment for secondary hyperparathyroidism in patients receiving hemodialysis.

Byrnes CA, Shepler BM.

Pharmacotherapy. 2005 May;25(5):709-16. Review.

PMID:
15899733
31.

Nitric oxide levels and ciliary beat frequency in indigenous New Zealand children.

Edwards EA, Douglas C, Broome S, Kolbe J, Jensen CG, Dewar A, Bush A, Byrnes CA.

Pediatr Pulmonol. 2005 Mar;39(3):238-46.

PMID:
15635620
32.

Treatment of paediatric non-cystic fibrosis bronchiectasis.

Edwards EA, Twiss J, Byrnes CA.

Expert Opin Pharmacother. 2004 Jul;5(7):1471-84. Review.

PMID:
15212598
33.

Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships.

Edwards EA, Metcalfe R, Milne DG, Thompson J, Byrnes CA.

Pediatr Pulmonol. 2003 Aug;36(2):87-93.

PMID:
12833486
34.

Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand.

Edwards EA, Asher MI, Byrnes CA.

J Paediatr Child Health. 2003 Mar;39(2):111-7.

PMID:
12603799
35.

Combined analysis of two multicenter studies of finasteride 5 mg in the treatment of symptomatic benign prostatic hyperplasia.

Byrnes CA, Liss CL, Tenover JL, Lippert MC, Gillenwater JY.

Prostate Cancer Prostatic Dis. 1997 Sep;1(1):26-31.

36.

Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants.

Vogel AM, Lennon DR, Broadbent R, Byrnes CA, Grimwood K, Mildenhall L, Richardson V, Rowley S.

J Paediatr Child Health. 2002 Dec;38(6):550-4. Review.

PMID:
12410864
37.

Humidification difficulties in two tracheostomized children.

Edwards EA, Byrnes CA.

Anaesth Intensive Care. 1999 Dec;27(6):656-8.

38.

Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial.

Lindsay R, Cosman F, Lobo RA, Walsh BW, Harris ST, Reagan JE, Liss CL, Melton ME, Byrnes CA.

J Clin Endocrinol Metab. 1999 Sep;84(9):3076-81.

PMID:
10487668
39.

Exhaled nitric oxide measurements in normal and asthmatic children.

Byrnes CA, Dinarevic S, Shinebourne EA, Barnes PJ, Bush A.

Pediatr Pulmonol. 1997 Nov;24(5):312-8.

PMID:
9407563
40.

Effect of measurement conditions on measured levels of peak exhaled nitric oxide.

Byrnes CA, Dinarevic S, Busst CA, Shinebourne EA, Bush A.

Thorax. 1997 Aug;52(8):697-701.

41.

Is nitric oxide in exhaled air produced at airway or alveolar level?

Byrnes CA, Dinarevic S, Busst C, Bush A, Shinebourne EA.

Eur Respir J. 1997 May;10(5):1021-5.

42.
43.

Measurement of expired nitric oxide levels in children.

Dinarevic S, Byrnes CA, Bush A, Shinebourne EA.

Pediatr Pulmonol. 1996 Dec;22(6):396-401.

PMID:
9016473
44.

Measuring expiratory nitric oxide in humans.

Byrnes CA, Bush A, Shinebourne EA.

Methods Enzymol. 1996;269:459-73. Review. No abstract available.

PMID:
8791675
47.

What's new in the diabetic diet.

Byrnes CA.

Nursing. 1987 Aug;17(8):58-9. No abstract available.

PMID:
3039427
48.

Acute renal failure due to interstitial nephritis resulting from radio-contrast agents.

Ihle BU, Byrnes CA, Simenhoff ML.

Aust N Z J Med. 1982 Dec;12(6):630-2. No abstract available.

PMID:
6962713

Supplemental Content

Loading ...
Support Center